B&M European Value Retail SA
OTC:BMRPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
B&M European Value Retail SA
OTC:BMRPF
|
LU |
|
WELL Health Technologies Corp
TSX:WELL
|
CA |
|
Orsted A/S
CSE:ORSTED
|
DK |
|
B
|
BWX Technologies Inc
F:4BW
|
US |
|
Aegon NV
F:AEND
|
NL |
|
Palatin Technologies Inc
OTC:PTNT
|
US |
|
A
|
AGL Energy Ltd
OTC:AGLNF
|
AU |
|
Biotest AG
F:BIO3
|
DE |
|
M
|
Mayr Melnhof Karton AG
F:MYM
|
AT |
|
D
|
Danone SA
SIX:DAN
|
FR |
Wall St Price Targets
BMRPF Price Targets Summary
B&M European Value Retail SA
According to Wall Street analysts, the average 1-year price target for BMRPF is 2.73 USD with a low forecast of 2.03 USD and a high forecast of 3.83 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BMRPF's stock price target?
Price Target
2.73
USD
According to Wall Street analysts, the average 1-year price target for BMRPF is 2.73 USD with a low forecast of 2.03 USD and a high forecast of 3.83 USD.
What is the Revenue forecast for B&M European Value Retail SA?
Projected CAGR
7%
Over the last 12 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 7 years is 7%.
What is the Operating Income forecast for B&M European Value Retail SA?
Projected CAGR
7%
Over the last 12 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 7 years is 7%.
What is the Net Income forecast for B&M European Value Retail SA?
Projected CAGR
-1%
Over the last 12 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 5 years is -1%.
